PerfinityiDP System
Shimadzu introduces the PerfinityiDP (integrated Digestion Platform) system. This online enzyme digestion HPLC system fully automates all processes from the enzymatic digestion of protein samples to the HPLC analysis of digested peptides
PerfinityiDP System
Shimadzu introduces the PerfinityiDP* (integrated Digestion Platform) system. This online enzyme digestion HPLC system fully automates all processes from the enzymatic digestion of protein samples to the HPLC analysis of digested peptides.
The PerfinityiDP uses a high-efficiency immobilized trypsin column for the online enzymatic digestion of proteins, it permits the online enzymatic digestion of proteins in less than one minute. The system iDP improves the analysis throughput by performing parallel processing of the stages from trypsin digestion to concentration in the desalting column and the stages from elution out of the desalting column to HPLC analysis.
The easy-to-use software supports method creation and selection for the series of processes from trypsin digestion to desalting and HPLC analysis.
An LC/MS can be added as a detector to automate the entire process up to analysis. Compared to conventional manual operations, the iDP offers more uniform control across the board and improves accuracy.
For more information please visit www.shimadzu.eu.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Innovative Solutions in Pre-Filled Syringes for Biologics and Ophthalmic Applications
May 5th 2025Don't miss this webinar delving into: - How to streamline the selection of the primary container and delivery device - How to overcome silicone challenges in PFSs - How to enhance the delivery of highly viscous drug formulation
Solving the Silicone Challenge in Pre-fillable Syringes
May 5th 2025The release of subvisible silicone particles and the risks associated with silicone oil droplets are major factors that can compromise the safety and efficacy of sensitive drugs. Download this white paper and discover how Stevanato Group's innovative syringe platform answers this challenge.
